Kar Hui Ng

Dr. Kar Hui Ng

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2008 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
JHJacqueline Ho
Jacqueline Ho
KNKar Hui Ng
Kar Hui Ng
SRSeymour Rosen
Seymour Rosen
ADAles Dostal
Ales Dostal
RGRichard I. Gregory
Richard I. Gregory
JKJordan A. Kreidberg
Jordan A. Kreidberg
MicroRNAs (miRNAs) are in a class of endogenous, small, noncoding RNAs that exert their effects through posttranscriptional repression of specific target mRNAs. Although miRNAs have been implicated in the regulation of diverse biologic processes, little is known about miRNA function in the kidney. Here, mice lacking functional miRNAs in the developing podocyte were generated through podocyte-specific knockout of Dicer, an enzyme required for the production of mature miRNAs (Nphs2-Cre; Dicerflx/flx). Podocyte-specific loss of miRNAs resulted in significant proteinuria by 2 wk after birth, rapid progression of marked glomerular and tubular injury beginning at 3 wk, and death by 4 wk. Expression of the slit diaphragm proteins nephrin and podocin was decreased, and expression of the transcription factor WT1 was relatively unaffected. To identify miRNA–mRNA interactions that contribute to this phenotype, we profiled the glomerular expression of miRNAs; three miRNAs expressed in glomeruli were identified: mmu-miR-23b, mmu-miR-24, and mmu-miR-26a. These results suggest that miRNA function is dispensable for the initial development of glomeruli but is critical to maintain the glomerular filtration barrier.

25 January 2016 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
SCSwasti Chaturvedi
Swasti Chaturvedi
KNKar Hui Ng
Kar Hui Ng
CMCherry Mammen
Cherry Mammen

1 August 2011 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
SESEVCAN AZIME BAKKALOGLU EZGU
SEVCAN AZIME BAKKALOGLU EZGU
DBDagmara Borzych
Dagmara Borzych
IHIl Soo Ha
Il Soo Ha
ESErkin Serdaroglu
Erkin Serdaroglu
RBRainer Büscher
Rainer Büscher
FNfor the International Pediatric Peritoneal Dialysis Network
for the International Pediatric Peritoneal Dialysis Network
Summary: Background and objectives: Left ventricular hypertrophy (LVH) is an independent risk factor and an intermediate end point of dialysis-associated cardiovascular comorbidity. We utilized a global pediatric registry to assess the prevalence, incidence, and predictors of LVH as well as its evolution in the longitudinal follow-up in dialyzed children. Design, setting, participants, & measurements: Cross-sectional echocardiographic, clinical, and biochemical data were evaluated in 507 children on peritoneal dialysis (PD), and longitudinal data were evaluated in 128 patients. The 95th percentile of LV mass index relative to height age was used to define LVH. Results: The overall LVH prevalence was 48.1%. In the prospective analysis, the incidence of LVH developing de novo in patients with normal baseline LV mass was 29%, and the incidence of regression from LVH to normal LV mass 40% per year on PD. Transformation to and regression from concentric LV geometry occurred in 36% and 28% of the patients, respectively. Hypertension, high body mass index, use of continuous ambulatory peritoneal dialysis, renal disease other than hypo/dysplasia, and hyperparathyroidism were identified as independent predictors of LVH. The use of renin-angiotensin system (RAS) antagonists and high total fluid output (sum of urine and ultrafiltration) were protective from concentric geometry. The risk of LVH at 1 year was increased by higher systolic BP standard deviation score and reduced in children with renal hypo/dysplasia. Conclusions: Using height-adjusted left ventricular mass index reference data, LVH is highly prevalent but less common than previously diagnosed in children on PD. Renal hypo/dysplasia is protective from LVH, likely because of lower BP and polyuria. Hypertension, fluid overload, and hyperparathyroidism are modifiable determinants of LVH.

1 July 2011 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
VSValerie Schumacher
Valerie Schumacher
USUrsula Schlötzer-Schrehardt
Ursula Schlötzer-Schrehardt
SKS. Ananth Karumanchi
S. Ananth Karumanchi
XSXiaofeng Shi
Xiaofeng Shi
JZJoseph Zaia
Joseph Zaia
XAXingbin Ai
Xingbin Ai
Paracrine signaling between podocytes and glomerular endothelial cells through vascular endothelial growth factor A (VEGFA) maintains a functional glomerular filtration barrier. Heparan sulfate proteoglycans (HSPGs), located on the cell surface or in the extracellular matrix, bind signaling molecules such as VEGFA and affect their local concentrations, but whether modulation of these moieties promotes normal crosstalk between podocytes and endothelial cells is unknown. Here, we found that the transcription factor Wilms9 Tumor 1 (WT1) modulates VEGFA and FGF2 signaling by increasing the expression of the 6-O-endosulfatases Sulf1 and Sulf2, which remodel the heparan sulfate 6-O-sulfation pattern in the extracellular matrix. Mice deficient in both Sulf1 and Sulf2 developed age-dependent proteinuria as a result of ultrastructural abnormalities in podocytes and endothelial cells, a phenotype similar to that observed in children with WT1 mutations and in Wt1+/− mice. These kidney defects associated with a decreased distribution of VEGFA in the glomerular basement membrane and on endothelial cells. Collectively, these data suggest that WT1-dependent sulfatase expression plays a critical role in maintaining the glomerular filtration barrier by modulating the bioavailability of growth factors, thereby promoting normal crosstalk between podocytes and endothelial cells.

1 February 2004 in Pediatrics
Verified
Journal Article
Open access
PDF file
KNKar Hui Ng
Kar Hui Ng
DCDaniel Chong
Daniel Chong
CWChin Khoon Wong
Chin Khoon Wong
HOHian Tat Ong
Hian Tat Ong
CLChien Yee Lee
Chien Yee Lee
LSLynette Shek
Lynette Shek
Objective. Allergic rhinitis is common and on the rise. Antihistamines are the mainstay of treatment and are the most commonly prescribed drugs in Singapore. Treatment-related sedation and its effect on cognition are a major concern. First- and second-generation antihistamines show varying degrees of sedation, but to date, objective studies in children are lacking. The objective of this study was to assess the sedating effect of cetirizine (second-generation antihistamine) and chlorpheniramine (first-generation antihistamine) compared with placebo using an objective neurophysiological test.Methods. This was a prospective, double-blind, placebo-controlled, randomized, single-dose, 3-way crossover study. Twenty-four children aged 7 to 14 years with allergic rhinitis completed the study. All children were randomly allocated to medication sequences and received 3 different drugs on 3 different days, at least 1 week apart. The P300 event-related potential was used as an objective test of sedation. Subjective assessment was by a visual analog scale.Results. Chlorpheniramine and cetirizine increased P300 latency when compared with baseline. No significant increase was obtained with placebo. The significant increase in P300 latency was not accompanied by significant change in subjective somnolence as measured by the visual analog scale.Conclusion. We have shown that cetirizine has sedative properties in children. The lack of correlation between P300 latency and the visual analog scale indicates that sedation induced by these drugs may not be subjectively noted.

1 November 2019 in Cell Host & Microbe
Verified
Journal Article
Closed access
KNKar Hui Ng
Kar Hui Ng
SZSummer Lixin Zhang
Summer Lixin Zhang
HTHwee Cheng Tan
Hwee Cheng Tan
SKSwee Sen Kwek
Swee Sen Kwek
OSOctober Michael Sessions
October Michael Sessions
HYHui-Kim Yap
Hui-Kim Yap